USPTO serial 88252211
BNO BIO CO., LTD.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 26, 2020
- Examiner
- FREEMAN, BREANNA SHALEISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BNO BIO CO., LTD.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treatment of hepatitis; pharmaceutical agents affecting sensory organs; pharmaceutical cold preparations for treating the common cold, sore throat, and fever; pharmaceutical products for the treatment of infectious diseases; thyroid and para-thyroid hormone preparations; tonics, namely, medicinal preparations for treating the common cold and medicinal herbal preparations; pharmaceutical preparations for treating hypertension; ibuprofen for use as an oral analgesic; parasiticides; bronchodilating preparations; pharmaceutical preparations for the treatment of disorders of the endocrine system; collyrium; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; nutritional supplements consisting primarily of magnesium; anesthetic preparations in the nature of anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity adjustment in particular for the treatment of immune system related diseases and disorders; athlete's foot preparations in the nature of ointments; pharmaceutical agents for treating physically caused lesions; pharmaceutical products for the treatment of viral diseases; vaccines; medicines for alleviating constipation; vitamin and mineral preparations for medical use; antiseptic preparations in the nature of antiseptic mouthwashes; fungicides; anti-inflammatory preparations; anti-inflammatory analgesic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular related diseases and disorders; ophthalmic preparations; allergy medications; medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; capsules for medicines, namely capsules sold empty for pharmaceuticals; pharmaceutical preparations, namely, pills for treating dizziness symptoms; disinfectants for hygiene purposes; gastro-intestinal treatment preparations; drugs for medical purposes, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicinal hair growth preparations; pharmaceutical and veterinary preparations namely, preparations for treatment of hepatitis for animals, pharmaceutical agents affecting sensory organs for animals, pharmaceutical cold preparations for treating the common cold, sore throat, and fever for animals, pharmaceutical products for the treatment of infectious diseases for animals, parasiticides for animals, pharmaceutical preparations for treating diabetes for animals, anesthetic preparations in the nature of anaesthetics for animals, pharmaceutical agents for treating physically caused lesions for animals, pharmaceutical products for the treatment of viral diseases for animals, vaccines for animals, medicines for alleviating constipation for animals, fungicides for animals, anti-inflammatory analgesic preparations for animals, pharmaceutical agents affecting digestive organs for animals, cardiovascular pharmaceutical preparations for the treatment of cardiovascular related diseases and disorders for animals, ophthalmic preparations for animals, allergy medications for animals, medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets for animals, disinfectants for hygiene purposes for animals, pharmaceutical preparations for the treatment of tumors for animals, antispasmodics for animals, preparation for pain relief for animals, medicinal preparations for skin treatment in particular for treatment of eczema, damaged skin and tissue, dry skin for animals, antibiotics for animals, antihistamines for animals, antipyretic preparations for animals, pharmaceutical preparations for respiratory organs in particular for treating respiratory diseases for animals, preparations for the treatment of burns for animals, chemotherapeutics for animals; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; antispasmodics; analgesic preparations; preparation for pain relief; dermatological pharmaceutical products; medicinal preparations for skin treatment in particular for treatment of eczema, damaged skin and tissue, dry skin; pharmaceutical preparations for anus in particular for the treatment of hemorrhoids, constipation; antibiotics; antihistamines; antipyretic preparations; blood solvent, namely, blood substitute for human use, pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for respiratory organs in particular for treating respiratory diseases; preparations for the treatment of burns; chemotherapeutics | ACTIVE | — |
| 035 | Procurement services, namely, purchasing pharmaceuticals for others; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; intermediary services featuring pharmaceuticals, namely, providing sales leads for the pharmaceutical industry, procurement of contracts for others for the purchase of pharmaceuticals; sales agency of pharmaceuticals, namely, independent sales representatives in the field of pharmaceuticals, retail store services featuring pharmaceuticals; sale arranging of pharmaceuticals, namely, independent sales representatives in the field of pharmaceuticals, retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical and veterinary preparations; retail store services featuring pharmaceutical and veterinary preparations; intermediary services featuring nutraceutical preparations for therapeutic or medical purposes, namely, providing sales leads for the nutraceutical industry, procurement of contracts for others for the purchase of nutraceutical preparations for therapeutic or medicinal purposes; procurement services, namely, purchasing nutraceutical preparations for therapeutic or medical purposes for others; retail store services featuring nutraceutical preparations for therapeutic or medical purposes; wholesale store services featuring nutraceutical preparations for therapeutic or medical purposes; sales agency of nutraceutical preparations for therapeutic or medical purposes, namely, independent sales representatives in the field of nutraceutical preparations for therapeutic or medical purposes, retail store services featuring nutraceutical preparations for therapeutic or medical purposes; sale arranging of nutraceutical preparations for therapeutic or medical purposes, namely, nutraceutical preparations for therapeutic or medical purposes, retail store services featuring nutraceutical preparations for therapeutic or medical purposes; sales agency of cosmetics, namely, independent sales representatives in the field of cosmetics, retail store services featuring cosmetics; procurement services, namely, purchasing cosmetics for others; wholesale store services featuring cosmetics; retail store services featuring cosmetics; intermediary services featuring cosmetics, namely, providing sales leads for the cosmetics industry, procurement of contracts for others for the purchase of cosmetics; sale arranging of cosmetics, namely, independent sales representatives in the field of cosmetics, retail store services featuring cosmetics | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; technical consultancy relating to research services in the field of foods and dietary supplements; scientific research in the field of biomedicine; scientific research in the field of crude medicines; product development in the field of cell therapy products; drug discovery services; development of pharmaceutical preparations and medicines; research and development in the field of pharmaceutical preparations and biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; inspection of pharmaceuticals; consultancy in the fields of pharmaceutical research and development; pharmaceutical research and development; clinical testing of medicines in the nature of testing of pharmaceuticals; pharmaceutical drug development services; medicine research, namely, medical research; medical research in the field of medical products; providing information in the fields of testing, inspection, or research of medical products in the nature of pharmaceuticals; conducting clinical trials for others | ACTIVE | — |
| 045 | Licensing of technology in the field of consumer health, healthcare, therapeutics, medical device and diagnostic, namely, legal administration of licenses; legal services; providing information on industrial property rights; legal services in the field of procedures relating to industrial property rights; licensing of industrial property rights; management of industrial property rights and copyright for others, namely, copyright management and providing legal services in the field industrial property; licensing of intellectual property in the field of trademarks; legal services relating to copyright licensing; copyright management; licensing of intellectual property in the field of copyrights; advisory services in the field of intellectual property licensing; legal services relating to the negotiation and drafting of contracts in the field of intellectual property rights for others; consultancy relating to the licensing of intellectual property; licensing of intellectual property; providing information in the field of intellectual property; licensing of patents and patent applications; patent licensing; professional legal advisory services in the field of infringement of patent rights; legal advisory services relating to patents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BNO BIO Co., Ltd.
- Other trademarks owned by BNO BIO Co., Ltd.
- Other trademarks owned by BNO BIO Co., Ltd.
- Other trademarks owned by BUKWANG PHARM. CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named BNO BIO CO., LTD.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 26, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 8, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 26, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 4, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 12, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 12, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 12, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 27, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |